T and B cells within the lung store long-term memory of SARS-CoV-2 infection
After infection with SARS-CoV-2, where does the immune system store the memory to provide long-term protection against reinfection? Though numerous
Read more
New cell-free antibody generation platform successfully creates neutralizing antibodies effective against SARS-CoV-2
Monoclonal antibodies have a multitude of uses – they can treat viral diseases such as coronavirus disease 2019 (COVID-19), be
Read more
Should pregnant women be vaccinated against COVID-19?
A recent review in the journal Vaccines examines whether coronavirus disease 2019 (COVID-19) risks in pregnant women justify the rare
Read more
Monoclonal antibody treatment combo can reduce the impact of COVID-19 in high-risk patients
In an observational study, Mayo Clinic researchers report that the combination of casirivimab and imdevimab – two monoclonal antibody treatments
Read more
Small study suggests a mix-and-match COVID-19 booster produces robust antibody levels
The United States is gearing up to provide boosters to all Americans who received the Pfizer-BioNTech and Moderna vaccines after
Read more
Study suggests mRNA SARS-CoV-2 vaccines remain effective against variants
The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused over four million
Read more
New test is cheaper, easier, and can reliably diagnose SARS-CoV-2 infection
New lateral flow test Vigilant is cheaper, easier to use and as reliable as the current gold standard PCR test
Read more
Study focuses on SARS-CoV-2 antibody seroprevalence in Wuhan and COVID-19 controls
Since the emergence in December 2019 in Wuhan, China, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide via
Read more
Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine
Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen. Three emergent SARS-like diseases
Read more
New research could rescue failed immunotherapies for treating solid tumors
New research from the UVA Cancer Center could rescue once-promising immunotherapies for treating solid cancer tumors, such as ovarian, colon
Read more